American Oncology Network, Inc. Class A Common Stock
AONC
AONC was delisted on the 7th of June, 2024.
79 hedge funds and large institutions have $301M invested in American Oncology Network, Inc. Class A Common Stock in 2022 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 7 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
86% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 7
7% more funds holding
Funds holding: 74 → 79 (+5)
2% more capital invested
Capital invested by funds: $296M → $301M (+$4.87M)
0% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
+$9.48M |
| 2 |
D.E. Shaw & Co
New York
|
+$7.52M |
| 3 |
CF
Cantor Fitzgerald
New York
|
+$4.91M |
| 4 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$3.97M |
| 5 |
SFM
Spartan Fund Management
Toronto, Ontario,
Canada
|
+$1.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCL
Glazer Capital LLC
New York
|
-$12.8M |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
-$8.85M |
| 3 |
HI
HBK Investments
Dallas,
Texas
|
-$7.47M |
| 4 |
MMA
Mizuho Markets Americas
New York
|
-$6.24M |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$3.2M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
UBS Group
Zurich,
Switzerland
| $12.8K | – | – | – |
|
|
TRCT
77
Tower Research Capital (TRC)
New York
| $3K | -$457 | -46 | -12% |
|
|
AS
78
AM Squared
Hong Kong
| $2.01K | +$1.99K | +200 | New |
|
|
WP
79
Woodline Partners
San Francisco,
California
| $1.08K | – | – | – |
|
|
80
BNP Paribas Financial Markets
Paris,
France
| – | -$8.85M | -1,125,000 | Closed |
|
|
HI
81
HBK Investments
Dallas,
Texas
| – | -$7.47M | -760,772 | Closed |
|
|
UOC
82
UBS O'Connor
Chicago,
Illinois
| – | -$3.2M | -325,945 | Closed |
|
|
HCM
83
Highbridge Capital Management
New York
| – | -$2.99M | -304,436 | Closed |
|
|
BCM
84
Basso Capital Management
Stamford,
Connecticut
| – | -$880K | -89,620 | Closed |
|
85
Barclays
London,
United Kingdom
| – | -$435K | -44,321 | Closed |
|
|
FTUS
86
Flow Traders U.S.
New York
| – | -$131K | -13,387 | Closed |
|
AONC Hedge Fund Activity: Q4 2022 in Review
79 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in American Oncology Network, Inc. Class A Common Stock (AONC) for Q4 2022, worth a combined $301M — up 1.6% from $296M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new AONC positions and 7 closed out — a net gain of 6 holders — while 11 added to existing stakes and 11 trimmed.
The largest buyer was HGC Investment Management, opening a new position worth an estimated $9.48M. The largest seller was Glazer Capital LLC, cutting an estimated $12.8M.
- 79 institutional investors held American Oncology Network, Inc. Class A Common Stock (AONC) as of Q4 2022, up from 74 in Q3 2022.
- Funds reported $301M of American Oncology Network, Inc. Class A Common Stock stock for Q4 2022, up 1.6% quarter-over-quarter.
- 13 funds opened new American Oncology Network, Inc. Class A Common Stock positions in Q4 2022 and 7 closed out, a net change of +6 holders.
- The largest American Oncology Network, Inc. Class A Common Stock buyer in Q4 2022 was HGC Investment Management, an estimated $9.48M added.
- The largest American Oncology Network, Inc. Class A Common Stock seller in Q4 2022 was Glazer Capital LLC, an estimated $12.8M sold.
Based on aggregated 13F filings for Q4 2022.